Drug Trial Radar · NCT01873768
Clinical Efficacy of Tranexamic Acid and ε-Aminocaproic Acid in Reducing Blood Loss Following Total Knee Replacement
Last checked: Nov 20, 2026Latest source record: Mar 21, 2016 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
194
Actual
Start
Jan 2014
Primary completion
Dec 2015
Study completion Dec 2015
Sponsor
- Lead sponsor
- Miller Orthopedic SpecialistsAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- CHI Health Mercy Hospital; Creighton University Medical Center
- First posted
- Jun 10, 2013
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 90 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Tranexamic acid (TXA) and ε-aminocaproic acid (EACA) are two drugs shown to limit blood loss following major surgery, from cardiac to orthopedic procedures. Yet compared to tranexamic acid (TXA), research on the clinical impact of ε-aminocaproic acid (EACA) in total knee arthroplasty (TKA) is limited. The primary aim of this study is to determine whether TXA and EACA provide similar blood decreasing effects following TKA or whether one drug provides a superior effect over the other in reducing patients' blood loss.
Conditions
- Osteoarthritis
Interventions
Tranexamic Acid (TXA)Drug
1g in 250cc of saline given over 30 minutes just prior to raising the tourniquet and making the initial incision. A second 1g in 250cc of saline will be infused over 30 minutes beginning at the time of wound closure.
ε-Aminocaproic Acid (EACA)Drug
7g in 250cc of saline given over 30 minutes just prior to raising the tourniquet and making the initial incision. A second 7g of EACA in 250cc saline will be infused over 30 minutes beginning at the time of wound closure.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Transfusion rateTime frame: 1.5 to 2 years
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Miller Orthopedic Specialists
Council Bluffs, Iowa
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.